share_log
Reuters ·  May 6 03:08
Ultragenyx Pharmaceutical Inc : Canaccord Genuity Cuts Target Price to $109 From $111
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment